They found that artemisinin boosted T cell functioning, blocked the immunosuppressive effects of Tregs and MDSCs, and allowed CD4+ IFN-γ+ T cells and cytotoxic T cells to thrive, all of which hindered tumor growth in vivo (64). The gene discussed is CD4; the disease is neoplasm.